Kaufman Bros. Starts Stryker (SYK) at Buy, Continues to See Growth
Tweet
Share
E-mailGet Alerts SYK Hot Sheet
Price: $339.21 -0.55%
Rating Summary:
33 Buy, 13 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
33 Buy, 13 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Kaufman Bros. initiates coverage on shares of Stryker (NYSE: SYK) with a Buy rating and $57 price target.
The firm reports that SYK's diversified platform allows its board to run the company with a portfolio management approach while the company's ability to generate strong cash flow offers acquisition possibilities and buybacks.
In the orthopedic sector, the company continues to see growth with the recent product launches and is beginning to benefit in the knee segment. Management has also been making a number of structural changes to improve margins.
An analyst at Kaufman comments, "Despite capex market challenges, MedSurg continues to post low-teens growth, which we have modeled to settle in the high-single digits."
For 2011 and 2012, the firm forecasts EPS of $3.71 and $4.10. Revenue for the two years is estimated to be $8.35 billion and $$8.86 billion.
For more ratings news on Stryker click here and for the rating history of Stryker click here.
Shares of Stryker closed at $47.23 yesterday.
The firm reports that SYK's diversified platform allows its board to run the company with a portfolio management approach while the company's ability to generate strong cash flow offers acquisition possibilities and buybacks.
In the orthopedic sector, the company continues to see growth with the recent product launches and is beginning to benefit in the knee segment. Management has also been making a number of structural changes to improve margins.
An analyst at Kaufman comments, "Despite capex market challenges, MedSurg continues to post low-teens growth, which we have modeled to settle in the high-single digits."
For 2011 and 2012, the firm forecasts EPS of $3.71 and $4.10. Revenue for the two years is estimated to be $8.35 billion and $$8.86 billion.
For more ratings news on Stryker click here and for the rating history of Stryker click here.
Shares of Stryker closed at $47.23 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Wolfe Research Downgrades Stryker (SYK) to Peerperform
- JPMorgan Resumes SanDisk (SNDK) at Overweight
- Seaport Global Securities Starts ADI Global Distribution (ADIG) at Buy
Create E-mail Alert Related Categories
New CoverageRelated Entities
Kaufman Bros.Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
